COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ:PTLA) announced today that on August 31, 2018, the Compensation Committee of the Board of Directors approved, [...]
Fluidigm to Participate at Upcoming Investor Events in September
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s management team will [...]
BeiGene to Present Data on Anti-PD-1 Antibody Tislelizumab at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto
05/09/2018
CAMBRIDGE, Mass. and BEIJING, China, Sept. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Avivagen Announces Q3 Financial Results and Proposed Extension of Warrants
05/09/2018
OTTAWA, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2018
05/09/2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers ERN France, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares composing the share [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 août 2018
05/09/2018
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers ERN France, 05 sept. 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital [...]
EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of C-Code for DEXYCU™
05/09/2018
WATERTOWN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Veritas Welcomes Exclusive Marketing Agreement Between 3 Carbon Extractions and ExtractionTek Solutions
05/09/2018
VANCOUVER, British Columbia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that its subsidiary, 3 Carbon [...]
Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
05/09/2018
Fiscal Year 2018 Revenue Rises 35% to $36.7 Million FARMINGDALE, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic [...]
Predictive Technology Group Announces Updated Presentation Time at the H.C. Wainwright 20th Annual Global Investment Conference
05/09/2018
Presentation and webcast to begin September 6 at 3:50 p.m. Eastern Time SALT LAKE CITY, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
05/09/2018
TUSTIN, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/09/2018
WAYNE, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Nuvectra to Participate in Two Upcoming Investor Conferences
05/09/2018
PLANO, Texas, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Adoption grows for Allscripts cutting edge Prescription Price Transparency Solution
05/09/2018
Incorporates real-time price data into prescribing workflow CHICAGO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, is delivering comprehensive [...]
Cara Therapeutics to Present at the 27th European Academy of Dermatology & Venereology Congress
05/09/2018
STAMFORD, Conn., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
05/09/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA [...]
Cytokinetics to Present at the Morgan Stanley Global Healthcare Conference
05/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at [...]
Get Ready for Flu Season With Oscillococcinum
05/09/2018
NEWTOWN SQUARE, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Last flu season was the worst in nearly a decade. Health experts are hoping that the intensity of last season will be a wake-up call to how serious flu can be, and [...]
Eckert & Ziegler BEBIG and Eckert & Ziegler Strahlen- und Medizintechnik AG are currently assessing the possibility of a merger between the two companies
05/09/2018
Press release Inside and regulated information 5 September 2018, 19:15 (CEST) Seneffe, Belgium, September 05, 2018. The board of directors of Eckert & Ziegler BEBIG SA ( BEBIG ) and the board of directors of Eckert [...]

Pages